Clinical Trial Update: Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

View source ↗

Summary

A completed clinical trial evaluating the effects of telmisartan (Micardis) and the MicardisPlus combination on metabolic parameters in patients with essential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Micardis (telmisartan)
• MicardisPlus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED